| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/27/1997 | EP0791602A1 A purification process of a human growth hormone |
| 08/27/1997 | EP0791601A2 An agent promoting bone formation and inhibiting bone resorption |
| 08/27/1997 | EP0791360A2 Treatment of septic shock with anti-TNF antibodies |
| 08/27/1997 | EP0791359A1 Remedy for diseases caused by il-6 production |
| 08/27/1997 | EP0791358A1 Remedy for ophthalmic diseases |
| 08/27/1997 | EP0791357A2 Use of gluten peptides as stimulator of mineral absorption and preventive agent of hyperlipidermia and hypercholesterolemia |
| 08/27/1997 | EP0791077A1 Methods for modulating transcription from the amyloid beta-protein precursor (app) promoter |
| 08/27/1997 | EP0791068A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 08/27/1997 | EP0791067A2 Protein kinase npk-110 |
| 08/27/1997 | EP0791065A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
| 08/27/1997 | EP0791060A2 Ribozyme analogs |
| 08/27/1997 | EP0791059A1 Production of recombinant peptides as natural hydrophobic peptide analogues |
| 08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
| 08/27/1997 | EP0791054A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease |
| 08/27/1997 | EP0791053A1 Porcine mesencephalic cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0791052A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0791050A1 Vectors for tissue-specific replication |
| 08/27/1997 | EP0791012A1 Peptides exhibiting oxytocin antagonistic activity |
| 08/27/1997 | EP0791011A2 Biologically active tgf-beta1 and tgf-beta2 peptides |
| 08/27/1997 | EP0791009A1 Modified neuropeptide y receptors |
| 08/27/1997 | EP0790982A1 Methods of synthesis of peptidyl argininals |
| 08/27/1997 | EP0790834A1 Composition containing pooled transferrins as an active principle for the induction of immune tolerance against antigens |
| 08/27/1997 | EP0790833A1 Process for identifying para cation channel modulators |
| 08/27/1997 | EP0790832A1 Topical preparation |
| 08/27/1997 | EP0790831A1 Method for reducing the severity of gastro-intestinal damage |
| 08/27/1997 | EP0790830A1 Trophinin and trophinin-assisting proteins |
| 08/27/1997 | EP0641216B1 PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6 stabilized with a non-reducing sugar |
| 08/27/1997 | EP0637966B1 Bystander effect tumoricidal therapy |
| 08/27/1997 | EP0607231B1 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 08/27/1997 | EP0594607B1 Enhancement of the down-regulation of autoimmune diseases by oral or enteral administration of autoantigens |
| 08/27/1997 | EP0547203B1 In vivo delivery of active factors by co-cultured cell implants |
| 08/27/1997 | EP0531425A4 Wound healing |
| 08/27/1997 | EP0400065B1 Lhrh analog |
| 08/27/1997 | CN1158144A Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 08/27/1997 | CN1158134A Antibodies which activate an erythropoietin receptor |
| 08/27/1997 | CN1158089A Pegylation reagents and compounds formed therewith |
| 08/27/1997 | CN1158087A Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 08/27/1997 | CN1157829A Process for producing platelet factor-4 |
| 08/27/1997 | CN1157828A Truncated form of inhibitory kappa B protein (IKB) recombinant production and uses thereof |
| 08/27/1997 | CN1157827A Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 08/27/1997 | CN1157826A Novel, ubiquitous potassium-channel proteins and genes for the same |
| 08/27/1997 | CA2198576A1 Pharmaceutical composition which comprises hirudin, and process for preparing it |
| 08/26/1997 | US5661179 Methods for treating neoplastic conditions using phenylacetic acid and derivatives thereof |
| 08/26/1997 | US5661161 Administering to treat cancer in mammals |
| 08/26/1997 | US5661150 Drug for neuroprotection |
| 08/26/1997 | US5661135 Human VEGF-specific oligonucleotides |
| 08/26/1997 | US5661130 Nontoxic, nonionic alkyl glycoside having a hydrophobic alkyl joined by a linkage to a hydrophilic saccharide |
| 08/26/1997 | US5661129 Organic nitrates containing a disulfide group as cardiovascular agents |
| 08/26/1997 | US5661128 Peptide inhibitors of farnesyl-protein transferase |
| 08/26/1997 | US5661127 Peptide compositions with growth factor-like activity |
| 08/26/1997 | US5661126 Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression |
| 08/26/1997 | US5661125 Stable and preserved erythropoietin compositions |
| 08/26/1997 | US5661124 Recombinantly produced mutant hemoglobin |
| 08/26/1997 | US5661123 Enteral composition for malabsorbing patients |
| 08/26/1997 | US5661122 Treatment of congestive heart failure |
| 08/26/1997 | US5661033 Gene transfer using herpes virus vectors as a tool for neuroprotection |
| 08/26/1997 | US5661020 Carboxylation; activation; covalently attaching to superoxide dismutase |
| 08/26/1997 | US5661015 Recombinant coccidiosis vaccines |
| 08/26/1997 | US5661009 Providing host cell transformed with dna encoding a consensus human leukocyte interferon, culturing cell to effect expression of dna |
| 08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
| 08/26/1997 | US5661005 Purified, isolated single-stranded dna sequence; culture product |
| 08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 08/26/1997 | US5661003 Dna encoding vasopressin-regulated water channel protein localized in kidney collecting tubule |
| 08/26/1997 | US5661001 High molecular weight desulphatohirudin |
| 08/26/1997 | US5660858 Cyclosporin emulsions |
| 08/26/1997 | US5660856 Pharmaceutical formulation and process |
| 08/26/1997 | US5660850 Injecting suspension of cells, cultured from skin biopsies of subject and treated with proteolytic enzymes, into defects or voids using hypodermic needles |
| 08/26/1997 | US5660846 Methods and apparatus for the delivery of solid drug compositions |
| 08/26/1997 | US5660828 Method of treating autoimmune and/or viral-induced diseases that are mediated by CD8 phenotype T cells |
| 08/26/1997 | US5660827 Antibodies that bind to endoglin |
| 08/26/1997 | US5660826 Administering to reduce or delay some of toxic effects of endotoxins or cytokines |
| 08/26/1997 | US5660825 Treating autoimmune disorders by administering protein complex deactivator |
| 08/26/1997 | US5660824 Muscle trophic factor |
| 08/26/1997 | US5660823 Fast drying, film forming iodine release solution |
| 08/26/1997 | US5660692 Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers |
| 08/26/1997 | CA1339389C Purified protein a compositions and methods for their preparation |
| 08/26/1997 | CA1339388C Atrial hypotensive peptide having 46 amino acids |
| 08/26/1997 | CA1339387C Magainins-synthetic antimicrobial compounds |
| 08/26/1997 | CA1339365C Oligopeptides and intermediates and processes for their manufacture |
| 08/26/1997 | CA1339363C Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
| 08/26/1997 | CA1339357C Gap gene sequences and diagnostic uses thereof |
| 08/26/1997 | CA1339356C Human platelet-derived growth factor receptor |
| 08/26/1997 | CA1339348C Novel glycopeptide antibiotics |
| 08/26/1997 | CA1339346C Recombinant chimeric vaccine |
| 08/26/1997 | CA1339345C Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
| 08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | WO1997030173A1 Monoclonal antibody that recognizes antigens present on the surface of endothelial cell of tumor vessel |
| 08/21/1997 | WO1997030167A1 Method of treating liver disorders |
| 08/21/1997 | WO1997030161A1 Hybrid proteins which form heterodimers |
| 08/21/1997 | WO1997030157A1 Novel human myeloid terminal differentiation response gene |
| 08/21/1997 | WO1997030156A2 NUCLEOTIDES AND PEPTIDES CORRESPONDING TO THE CANINE IgE HEAVY CHAIN CONSTANT REGION AND RELATED METHODS |
| 08/21/1997 | WO1997030153A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 08/21/1997 | WO1997030151A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation |
| 08/21/1997 | WO1997030150A2 Molecules for the induction of immunological tolerance |
| 08/21/1997 | WO1997030149A1 Novel era |
| 08/21/1997 | WO1997030146A2 Cardiotrophin and uses therefor |
| 08/21/1997 | WO1997030108A1 Characterized brca1 and brca2 proteins and screening and therapeutic methods based on characterized brca1 and brca2 proteins |
| 08/21/1997 | WO1997030089A1 Novel antibody-cytokine fusion protein, and methods of making and using the same |
| 08/21/1997 | WO1997030088A2 Methods of treating vascular disease with tnf antagonists |